pharma · Metachromatic Leukodystrophy (MLD) · Late Metachromatic Leukodystrophy (MLD)
Shire
Shire clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- JP
- Employees
- 3,523
- Programs
- 9
- Drugs
- 8
- Patents
- 0
Shire projects
9 ClinicalTrials.gov programs sponsored by Shire.
Shire has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Maribavir
Shire
Cytomegalovirus (CMV)
2 trials -
Ontamalimab
Shire
Crohn's Disease
1 trial -
SHP615
Shire
Nervous System Diseases
1 trial -
velaglucerase alfa
Shire
Gaucher Disease
1 trial -
Recombinant human arylsulfatase A
Shire
Metachromatic Leukodystrophy (MLD)
1 trial -
SHP611
Shire
Metachromatic Leukodystrophy (MLD)
1 trial -
rhASA
Shire
Late Metachromatic Leukodystrophy (MLD)
1 trial -
rhASA
Shire
Late Metachromatic Leukodystrophy (MLD)
1 trial -
Elaprase for intravenous (IV) infusion
Shire
Hunter Syndrome
1 trial
Frequently asked questions
How many clinical projects does Shire have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.